Focal Therapy for Renal Cancer: Comparative Trends in the USA and Germany from 2006 to 2020 and Analysis of the German Health Care Landscape.
Urol Int
; 107(4): 396-405, 2023.
Article
em En
| MEDLINE
| ID: mdl-36702105
ABSTRACT
INTRODUCTION:
The aim of the study was to investigate trends of FT for in-patient treatment of renal RCC in the USA and Germany.METHODS:
We analyzed the SEER database for the USA and the nationwide German hospital billing database each from 2006 to 2019 for a RCC diagnosis in combination with FT, radical nephrectomy, and partial nephrectomy. FT was defined as radiofrequency ablation (RFA) or cryotherapy. Linear regression analysis was performed to detect changes over time.RESULTS:
For the USA, we included 7,318 FT cases. The share of FT increased from 2.4% in 2006 to 6.4% in 2019 (p < 0.001). For Germany, we identified 2,920 FT cases. The share of FT increased from 0.7% in 2006 to 2.0% in 2019 (p < 0.001). The number of RFAs in the USA steadily increased by 227% from a total of 93 in 2006 to 304 in 2019 while the number of cryotherapies in the USA steadily increased by 289% from a total of 127 in 2006 to 494 in 2019 (p < 0.001). The number of RFAs in Germany increased by 344% from a total of 59 in 2006 to 262 in 2019 (p < 0.001) while the number of cryotherapies steadily increased by 43% from a total of 54 in 2006 to 77 in 2019 (p < 0.001). In Germany, RFA is significantly more performed than cryotherapy while in the USA cryotherapy is more frequently applied.CONCLUSION:
We observed a constant increase of FT in the USA and Germany for RCC in-patient treatment with a higher share in the USA.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Próstata
/
Carcinoma de Células Renais
/
Neoplasias Renais
Limite:
Humans
/
Male
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Urol Int
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Alemanha